ACCENDRA HEALTH INC (ACH) Stock Earnings Estimates
USA • New York Stock Exchange • NYSE:ACH • US6907321029
2.21 USD
+0.13 (+6.25%)
At close: Jan 30, 2026
2 USD
-0.21 (-9.5%)
After Hours: 1/30/2026, 8:04:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.955B 1.74% | 10.334B 3.80% | 10.701B 3.55% | 2.797B -73.86% | 2.63B -5.97% | 2.776B 5.55% | 3.072B 10.66% | N/A | |
| EBITDA YoY % growth | 426.602M -13.50% | 609.549M 42.88% | 513.399M -15.77% | 383.63M -25.28% | 359.8M -6.21% | 380.72M 5.81% | N/A | N/A | |
| EBIT YoY % growth | 197.935M -50.83% | 322.172M 62.77% | 248.624M -22.83% | 230.5M -7.29% | 219.36M -4.83% | 241.54M 10.11% | N/A | N/A | |
| Operating Margin | 1.99% | 3.12% | 2.32% | 8.24% | 8.34% | 8.70% | N/A | N/A | |
| EPS YoY % growth | 2.41 -42.34% | 1.36 -43.57% | 1.52 11.76% | 1.04 -31.69% | 0.95 -8.82% | 1.19 25.29% | 1.28 8.14% | 1.45 13.39% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.22 -59.45% | 0.15 -36.11% | 0.20 -21.34% | 0.26 4.54% | 0.31 40.38% | 0.20 37.46% | 0.23 13.58% | 0.29 12.08% | 0.31 |
| Revenue Q2Q % growth | 721.88M -73.22% | 654.03M -75.15% | 638.1M -6.43% | 659.73M -5.39% | 678.89M -5.96% | 682.31M 4.32% | 690.45M 8.20% | 730.4M 10.71% | 749.58M 10.41% |
| EBITDA Q2Q % growth | 91.736M -73.55% | 82.325M -24.31% | 86.111M -49.28% | 91.87M -56.62% | 99.47M 8.43% | 88.708M 7.75% | 91.718M 6.51% | 99.869M 8.71% | 102.45M 3.00% |
| EBIT Q2Q % growth | 56.048M -31.68% | 46.935M -1.44% | 52.139M 5.91% | 58.161M 114.38% | 65.054M 16.07% | 53.49M 13.97% | 56.499M 8.36% | 64.65M 11.16% | 67.236M 3.35% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.25 -40.48% | 0.23 | 0.02 | 6.69% |
| Q2 2025 Q2Q % growth | 0.26 -27.78% | 0.28 | -0.02 | -6.28% |
| Q1 2025 Q2Q % growth | 0.23 21.05% | 0.20 | 0.03 | 16.66% |
| Q4 2024 Q2Q % growth | 0.55 -20.29% | 0.52 | 0.03 | 4.84% |
| Q3 2024 Q2Q % growth | 0.42 -4.55% | 0.42 | 0.00 | 0.62% |
| Q2 2024 Q2Q % growth | 0.36 100.00% | 0.33 | 0.03 | 8.73% |
| Q1 2024 Q2Q % growth | 0.19 280.00% | 0.18 | 0.01 | 5.18% |
| Q4 2023 Q2Q % growth | 0.69 146.43% | 0.67 | 0.02 | 2.91% |
| Q3 2023 Q2Q % growth | 0.44 7.32% | 0.38 | 0.06 | 16.30% |
| Q2 2023 Q2Q % growth | 0.18 -76.32% | 0.18 | 0.00 | 0.78% |
| Q1 2023 Q2Q % growth | 0.05 -94.79% | -0.09 | 0.14 | 154.00% |
| Q4 2022 Q2Q % growth | 0.28 -65.43% | 0.41 | -0.13 | -30.92% |
| Q3 2022 Q2Q % growth | 0.41 -44.59% | 0.40 | 0.01 | 3.34% |
| Q2 2022 Q2Q % growth | 0.76 -28.30% | 0.77 | -0.01 | -1.02% |
| Q1 2022 Q2Q % growth | 0.96 -38.85% | 0.83 | 0.13 | 15.47% |
| Q4 2021 Q2Q % growth | 0.81 -28.95% | 0.71 | 0.10 | 13.43% |
| Q3 2021 Q2Q % growth | 0.74 -8.64% | 0.55 | 0.19 | 33.41% |
| Q2 2021 Q2Q % growth | 1.06 430.00% | 1.00 | 0.06 | 5.64% |
| Q1 2021 Q2Q % growth | 1.57 3,825.00% | 1.00 | 0.57 | 56.41% |
| Q4 2020 Q2Q % growth | 1.14 | 0.86 | 0.28 | 32.71% |
| Q3 2020 Q2Q % growth | 0.81 | 0.72 | 0.09 | 13.11% |
| Q2 2020 Q2Q % growth | 0.20 | 0.20 | 0.00 | 1.29% |
| Q1 2020 Q2Q % growth | 0.04 | 0.04 | 0.00 | 3.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 697.3M -74.37% | 1.146B | -448.7M | -39.15% |
| Q2 2025 Q2Q % growth | 681.917M -74.47% | 2.759B | -2.077B | -75.28% |
| Q1 2025 Q2Q % growth | 2.632B 0.74% | 2.689B | -56.952M | -2.12% |
| Q4 2024 Q2Q % growth | 2.696B 1.50% | 2.712B | -15.927M | -0.59% |
| Q3 2024 Q2Q % growth | 2.721B 4.99% | 2.707B | 14.125M | 0.52% |
| Q2 2024 Q2Q % growth | 2.671B 4.20% | 2.673B | -1.994M | -0.07% |
| Q1 2024 Q2Q % growth | 2.613B 3.56% | 2.636B | -23.32M | -0.88% |
| Q4 2023 Q2Q % growth | 2.656B 4.12% | 2.696B | -39.85M | -1.48% |
| Q3 2023 Q2Q % growth | 2.592B 3.78% | 2.604B | -12.258M | -0.47% |
| Q2 2023 Q2Q % growth | 2.563B 2.53% | 2.516B | 47.226M | 1.88% |
| Q1 2023 Q2Q % growth | 2.523B 4.82% | 2.428B | 94.849M | 3.91% |
| Q4 2022 Q2Q % growth | 2.551B 3.40% | 2.485B | 66.107M | 2.66% |
| Q3 2022 Q2Q % growth | 2.497B -0.19% | 2.423B | 74.401M | 3.07% |
| Q2 2022 Q2Q % growth | 2.5B 0.42% | 2.569B | -68.985M | -2.69% |
| Q1 2022 Q2Q % growth | 2.407B 3.46% | 2.331B | 75.952M | 3.26% |
| Q4 2021 Q2Q % growth | 2.467B 4.46% | 2.458B | 9.146M | 0.37% |
| Q3 2021 Q2Q % growth | 2.502B 14.36% | 2.487B | 15.175M | 0.61% |
| Q2 2021 Q2Q % growth | 2.489B 37.71% | 2.5B | -10.54M | -0.42% |
| Q1 2021 Q2Q % growth | 2.327B 9.60% | 2.394B | -67.5M | -2.82% |
| Q4 2020 Q2Q % growth | 2.362B | 2.185B | 176.8M | 8.09% |
| Q3 2020 Q2Q % growth | 2.188B | 2.098B | 89.9M | 4.29% |
| Q2 2020 Q2Q % growth | 1.808B | 1.972B | -164.3M | -8.33% |
| Q1 2020 Q2Q % growth | 2.123B | 2.106B | 16.7M | 0.79% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |